AgenTus Therapeutics is a dynamic new start-up subsidiary developing T cell receptors (TCRs) and chimeric antigen receptors (CARs) designed to supercharge human immune effector cells to seek and destroy cancer. We aim to deliver cures to cancer patients around the world by leveraging our proprietary platforms for TCR discovery, targeting novel phosphopeptide neo-epitopes and developing unique allogeneic cell therapies. Together with our parent company, Agenus, we have a deep and diverse repertoire of immunotherapy treatments that can be used in combinations that will synergize to help the body’s immune system fight cancer.

What are we looking for?

  • Leading the way: A creative and learning-agile team member, willing to challenge the status quo
  • Ownership: A partner to jointly own our company’s goals, execution and success
  • Working together: A colleague to thrive on collaboration with our global teammates
  • Loving what you do: A team member with positive energy that is passionate about our mission


To search careers click here  

Back to Top